Autologous Dendritic Cells for Treatment of Advanced Cancer — An Update-Reference-Cited by-同舟云学术

Autologous Dendritic Cells for Treatment of Advanced Cancer — An Update

Published:2001 Issue: Volume: Page:236-248
ISSN:0080-0015
Container-title:Minimal Residual Disease in Melanoma
language:
Short-container-title:

Author:

Schadendorf D.,Nestle F. O.

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/978-3-642-59537-0_24.pdf

Reference103 articles.

1. Abdel-Wahab Z et al. (1998) Human dendritic cells, pulsed with either melanoma tumor cell lysates or the gp100 peptide (280–288), induce pairs of T-cell cultures with similar phenotype and lyric activity. Cell Immunol 186: 63–74

2. Ahmann DL et al. (1989) Complete responses and long-term survivals after systemic chemotherapy for patients with advanced malignant melanoma. Cancer 63: 224–227

3. Alijagic S et al. (1995) Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T cell activation. Eur J Immunol 25, 3100–3107 Banchereau J and Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392: 245–252

4. Bell D et al. (1999) Dendritic cells. Adv Immunol 72: 255–324

5. Bennett SRM et al. (1997) Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ help, J Exp Med 186, 65–70

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro use of autologous dendritic cells improves detection of T cell responses to hepatitis B virus (HBV) antigens;Journal of Medical Virology;2009-02

2. Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting;Melanoma Research;2008-04

3. Update on vaccines for melanoma patients;Expert Review of Dermatology;2008-04

4. Multicenter study on in vitro characterization of dendritic cells;Cytotherapy;2008

5. Differentiation of monocyte-derived dendritic cells under the influence of platelets;Cytotherapy;2008-01